drugset / Trial / NCT00595699

Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy

NCT00595699

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a research study evaluating the use of escitalopram (Lexapro®) for the treatment of major depression in subjects with temporal lobe epilepsy. The purpose of the study is to measure the severity and change in depressive and anxiety symptoms after 10 weeks of study treatment with escitalopram or placebo as measured by certain rating scales and questionnaires. In addition, the study will measure the frequency of seizures using a patient diary during the study. Finally, the study will assess the change in the quality of life using rating scales.

Timeline

Start
2006-11
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 20 mg